Champion in early phase research and whole person care
We don’t treat diseases, we treat people.
As a skin cancer specialist and clinical researcher at University College London Hospitals and Mount Vernon Cancer Centre, her days are spent driving groundbreaking research while providing compassionate care to patients and their families, with recognition that each person that walks through her exam room door, is so much more than someone living with cancer.
Dr. Shaw’s path into skin cancer care began in the laboratory, as she pursued research in melanocyte biology. This exposure to pigment cell science, combined with an understanding of the importance of sun protection that was instilled into her early on by her mother, sparked an interest that turned into a professional calling.
What ultimately drew her to skin cancer was its role at the forefront of cancer innovation. During her training, immunology became the engine driving transformational therapies. Skin cancer emerged as the proving ground for first‑in‑human studies and breakthrough immunotherapies, shaping progress for innovation in cancer care across tumor types.
Today, Dr. Shaw continues to work in early‑phase, first-in-human research, now driving the groundbreaking research she once admired.
For Dr. Shaw, the measure of great patient care extends far beyond clinical outcomes. She sees and treats the “whole human,” driven by the understanding that each person who sits across from her is a unique individual, with families, responsibilities, ambitions and the need to carry on with everyday life in spite of their life-altering diagnosis.
Beyond just relevant information about Bristol Myers Squibb's therapeutic areas and innovation, Our stories offer a window into the work our employees do every day for patients.
You've got a whole human being in front of you and all their ecosystem around them. Their family, the people they care for and the people that care for them.
Dr. Shaw is guided by a staunch belief: that every patient deserves personalized care. Each decision is tailored to the individual, not the diagnosis. She also measures the quality of her day by the type of day her patients are having: if the patient is having a good day, the care team is having a good day too. That belief guides how she and her multidisciplinary teams think about care, not just physically, but emotionally and practically.
A defining focus of Dr. Shaw’s research is improving outcomes for patients who fall into what she calls the “gap” — those who don’t respond to first‑line therapy or whose disease lacks strong treatment options altogether.
Rather than accepting these limitations, she focuses on how to close that gap: advocating for early detection, developing better strategies after disease progression and advancing care for rare and difficult‑to‑treat cancers such as uveal (ocular) melanoma.
Looking ahead, Dr. Shaw envisions a future where skin cancer is diagnosed early — and treated effectively enough — that patients never reach life‑threatening stages of disease.
As a Champion in Care, Dr. Heather Shaw exemplifies the belief that progress in cancer medicine must always be matched by compassion. Through her leadership, research and unwavering commitment to patients, she is helping build a future where innovation serves people, not just fights disease, and where every patient is cared for as the individual they are.
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. As global citizens, we work sustainably and responsibly to create a positive impact in the communities where we live and work.